Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Grebely

Showing results (61-70 of 368) with videos related to

Pageof 37
Sort By:
The International Journal on Drug Policy|June 6, 2017
Estimating the cascade of hepatitis C testing, care and treatment among people who inject drugs in AustraliaJenny Iversen, Jason Grebely, Beth Catlett, et al.
Journal of Hepatology|October 28, 2018
Association between rapid utilisation of direct hepatitis C antivirals and decline in the prevalence of viremia among people who inject drugs in AustraliaJenny Iversen, Gregory J Dore, Beth Catlett, et al.
The International Journal on Drug Policy|January 3, 2026
Service provider perceptions of incorporating hepatitis C testing technologies into standard practice: Considerations for widespread implementation and scale-upAlex R Willing, Guillaume Fontaine, Carla Treloar, et al.
Annals of Internal Medicine|February 3, 2016
Hepatitis C Virus Treatment and Persons Who Inject DrugsJason Grebely, Gregory J Dore, Robert Greenwald, et al.
The International Journal on Drug Policy|February 12, 2020
Perceptions and concerns of hepatitis C reinfection following prison-wide treatment scale-up: Counterpublic health amid hepatitis C treatment as prevention efforts in the prison settingLise Lafferty, Jake Rance, Jason Grebely, et al.
Sexual Health|April 1, 2020
Estimated uptake of hepatitis C direct-acting antiviral treatment among individuals with HIV co-infection in Australia: a retrospective cohort studyNima Iranpour, Gregory J Dore, Marianne Martinello, et al.
Journal of Viral Hepatitis|August 25, 2018
Understanding facilitators and barriers of direct-acting antiviral therapy for hepatitis C virus infection in prisonLise Lafferty, Jake Rance, Jason Grebely, et al.
Journal of Viral Hepatitis|December 20, 2022
Hepatitis C care cascade before and during the direct-acting antiviral eras in New South Wales, Australia: A population-based linkage studyMohammad T Yousafzai, Maryam Alavi, Heather Valerio, et al.
The International Journal on Drug Policy|September 11, 2017
Elimination of hepatitis C virus infection among PWID: The beginning of a new era of interferon-free DAA therapyJason Grebely, Julie Bruneau, Philip Bruggmann, et al.
Hepatology (Baltimore, Md.)|October 24, 2006
Hepatitis C virus reinfection in injection drug usersJason Grebely, Brian Conway, Jesse D Raffa, et al.
Pageof 37

Showing results (61-70 of 368) with videos related to

Sort By:
Pageof 37
The International Journal on Drug Policy|June 6, 2017
Estimating the cascade of hepatitis C testing, care and treatment among people who inject drugs in AustraliaJenny Iversen, Jason Grebely, Beth Catlett, et al.
Journal of Hepatology|October 28, 2018
Association between rapid utilisation of direct hepatitis C antivirals and decline in the prevalence of viremia among people who inject drugs in AustraliaJenny Iversen, Gregory J Dore, Beth Catlett, et al.
The International Journal on Drug Policy|January 3, 2026
Service provider perceptions of incorporating hepatitis C testing technologies into standard practice: Considerations for widespread implementation and scale-upAlex R Willing, Guillaume Fontaine, Carla Treloar, et al.
Annals of Internal Medicine|February 3, 2016
Hepatitis C Virus Treatment and Persons Who Inject DrugsJason Grebely, Gregory J Dore, Robert Greenwald, et al.
The International Journal on Drug Policy|February 12, 2020
Perceptions and concerns of hepatitis C reinfection following prison-wide treatment scale-up: Counterpublic health amid hepatitis C treatment as prevention efforts in the prison settingLise Lafferty, Jake Rance, Jason Grebely, et al.
Sexual Health|April 1, 2020
Estimated uptake of hepatitis C direct-acting antiviral treatment among individuals with HIV co-infection in Australia: a retrospective cohort studyNima Iranpour, Gregory J Dore, Marianne Martinello, et al.
Journal of Viral Hepatitis|August 25, 2018
Understanding facilitators and barriers of direct-acting antiviral therapy for hepatitis C virus infection in prisonLise Lafferty, Jake Rance, Jason Grebely, et al.
Journal of Viral Hepatitis|December 20, 2022
Hepatitis C care cascade before and during the direct-acting antiviral eras in New South Wales, Australia: A population-based linkage studyMohammad T Yousafzai, Maryam Alavi, Heather Valerio, et al.
The International Journal on Drug Policy|September 11, 2017
Elimination of hepatitis C virus infection among PWID: The beginning of a new era of interferon-free DAA therapyJason Grebely, Julie Bruneau, Philip Bruggmann, et al.
Hepatology (Baltimore, Md.)|October 24, 2006
Hepatitis C virus reinfection in injection drug usersJason Grebely, Brian Conway, Jesse D Raffa, et al.
Pageof 37